Meet our Research Directors and Scientists at British Pharmacological Society (BPS) Conference in London this week, where we attend with strong presence of 3 oral presentation and 6 posters! For posters see the poster session, for orals:
- Omiganan demonstrates pharmacodyamic and clinical activity in patients with mild to moderate atopic dermatitis in a phase II proof-of-concept RCT: By Robert Rissmann, Tuesday, 16:15.
- Imiquimod induced skin inflammation - a human model for drug development programs: By Tessa van der Kolk, Tuesday, 15:30.
- Safety, pharmacokinetics and pharmacodynamics of repeat doses of intranasal Memogain®, a prodrug of galantamine, in healthy elderly subjects: By Charlotte Bakker, Tuesday, 15:15.
